Study: HDL cholesterol, heart risk aren't linked in statin users

07/22/2010 | HealthDay News

A U.S. study suggests that patients with a low level of LDL, or "bad," cholesterol as a result of using a high-dose statin, such as AstraZeneca's Crestor, might not benefit from a high level of HDL, or "good," cholesterol. The finding suggests that "once on a high-dose statin, it is unclear if HDL cholesterol remains an important determinant of residual risk" of cardiovascular disease, the lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC